{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:03:46Z","timestamp":1693112626064},"reference-count":0,"publisher":"Elmer Press, Inc.","issue":"1-2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Hematol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.14740\/jh596","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T07:51:11Z","timestamp":1587628271000},"page":"30-32","source":"Crossref","is-referenced-by-count":3,"title":["Prolonged Remission by Pembrolizumab and Brentuximab-Vedotin Combination Therapy in Heavily-Pretreated Relapsed\/Refractory Hodgkin\u2019s Lymphoma"],"prefix":"10.14740","volume":"9","author":[{"given":"Tsung-Ying","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Shen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5784","container-title":["Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thejh.org\/index.php\/JH\/article\/download\/596\/471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T07:51:17Z","timestamp":1587628277000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thejh.org\/index.php\/JH\/article\/view\/596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":0,"journal-issue":{"issue":"1-2"},"alternative-id":["10.14740\/jh596"],"URL":"https:\/\/doi.org\/10.14740\/jh596","relation":{},"ISSN":["1927-1212","1927-1220"],"issn-type":[{"value":"1927-1212","type":"print"},{"value":"1927-1220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}